In hospital outcomes of autologous and implant‐based breast reconstruction in patients with chronic obstructive pulmonary disease

Renxi Li,Bharat Ranganath
DOI: https://doi.org/10.1002/wjs.12139
IF: 3.282
2024-03-20
World Journal of Surgery
Abstract:Background Chronic obstructive pulmonary disease (COPD) is a common comorbid condition that can be associated with postoperative mortality and morbidity. However, the outcome profile of patients with COPD after breast reconstruction has yet to be established. Therefore, this study aimed to assess the postoperative outcomes in patients with COPD who underwent autologous (ABR) and implant‐based breast reconstruction (IBR). Methods National Inpatient Sample was used to identify patients who underwent ABR or IBR from Q4 2015 to 2020. Multivariable logistic regressions were used to compare inhospital outcomes between COPD and non‐COPD patients while adjusting for demographics, primary payer status, hospital characteristics, and comorbidities. Results There were 1288 (9.92%) COPD and 11,696 non‐COPD patients who underwent ABR. Meanwhile, 1742 (9.70%) COPD and 16,221 non‐COPD patients underwent IBR. In both ABR and IBR, patients with COPD had higher rates of seroma (ABR, aOR = 1.863, 95% CI = 1.022–3.397, and p = 0.04; IBR, aOR = 1.524, 95% CI = 1.014–2.291, and p = 0.04), infection (ABR, aOR = 1.863, 95% CI = 1.022–3.397, and p = 0.04; IBR, aOR = 1.956, 95% CI = 1.205–3.176, and p = 0.01), and prolonged LOS (p
surgery
What problem does this paper attempt to address?